NEW YORK, April 13 (GenomeWeb News) - Interleukin Genetics has signed a new lease that expands its Waltham, Mass.-based facilities from 6,000 to 19,000 square feet, the company said today.
Interleukin said it would use the new space to build a CLIA (Clinical Laboratory Improvement Act)-certified DNA laboratory to process DNA tests that it plans to launch next year.
In line with its expansion plans, Interleukin hired four new managers: Taha Keilani as medical director; Christopher Palatucci as senior director of business development and licensing; Paul Voegelin as director of operations and planning; and Gary Breton as DNA laboratory manager.